BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8286739)

  • 1. Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency.
    Mitchell L; Hoogendoorn H; Giles AR; Vegh P; Andrew M
    Blood; 1994 Jan; 83(2):386-91. PubMed ID: 8286739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fresh frozen plasma has no beneficial effect on the hemostatic system in children receiving L-asparaginase.
    Halton JM; Mitchell LG; Vegh P; Eves M; Andrew ME
    Am J Hematol; 1994 Nov; 47(3):157-61. PubMed ID: 7524313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different profile of thrombin generation in children with acute lymphoblastic leukaemia treated with native or pegylated asparaginase: A cohort study.
    Rozen L; Noubouossie D; Dedeken L; Huybrechts S; Lê PQ; Ferster A; Demulder A
    Pediatr Blood Cancer; 2017 Feb; 64(2):294-301. PubMed ID: 27605400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Children with acute lymphoblastic leukemia: is there any subgroup of children without elevated thrombin generation? A preliminary study utilizing measurements of thrombin-antithrombin III complexes.
    Uszyński M; Osińska M; Zekanowska E; Ziółkowska E
    Med Sci Monit; 2000; 6(1):108-11. PubMed ID: 11208295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-asparaginase induced antithrombin III deficiency: evidence against the production of a hypercoagulable state.
    Bauer KA; Teitel JM; Rosenberg RD
    Thromb Res; 1983 Feb; 29(4):437-42. PubMed ID: 6857592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired antithrombin III deficiency secondary to asparaginase therapy in childhood acute lymphoblastic leukaemia.
    Andrew M; Brooker L; Mitchell L
    Blood Coagul Fibrinolysis; 1994 Jan; 5 Suppl 1():S24-36; discussion S59-64. PubMed ID: 8186353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with L-asparaginase: an in vitro study.
    Kuhle S; Lau A; Bajzar L; Vegh P; Halton J; Cherrick I; Anderson R; Desai S; McCusker P; Wu J; Abshire T; Mahoney D; Mitchell L
    Br J Haematol; 2006 Sep; 134(5):526-31. PubMed ID: 16856890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia.
    Mitchell LG; Halton JM; Vegh PA; Barr RD; Venneri T; Pai KM; Andrew ME
    Am J Pediatr Hematol Oncol; 1994 May; 16(2):120-6. PubMed ID: 8166364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness of Peg-Asparaginase and L-Asparaginase on Coagulation Markers Among Pediatric Patients with Acute Lymphoblastic Leukemia.
    Zekavat OR; Safari A; Bordbar MR; Haghpanah S; Zareifar S; Shahriari M; Mohammadzadeh M
    Clin Lab; 2022 Feb; 68(2):. PubMed ID: 35142188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase.
    Oner AF; Gürgey A; Kirazli S; Okur H; Tunç B
    Leuk Lymphoma; 1999 Apr; 33(3-4):361-4. PubMed ID: 10221516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children.
    Mitchell L; Piovella F; Ofosu F; Andrew M
    Blood; 1991 Nov; 78(9):2299-304. PubMed ID: 1718494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin III infusion suppresses the hypercoagulable state in adult acute lymphoblastic leukaemia patients treated with a low dose of Escherichia coli L-asparaginase. A GIMEMA study.
    Mazzucconi MG; Gugliotta L; Leone G; Dragoni F; Belmonte MM; De Stefano V; Chistolini A; Tura S; Mandelli F
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):23-8. PubMed ID: 7514043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostasis in childhood acute lymphoblastic leukemia: coagulopathy induced by disease and treatment.
    Mitchell LG; Sutor AH; Andrew M
    Semin Thromb Hemost; 1995; 21(4):390-401. PubMed ID: 8747702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin supplementation III in childhood acute lymphoblastic leukemia treated with L-asparaginase.
    Matsuzaki A; Suminoe A; Hara T
    Pediatr Hematol Oncol; 2002 Dec; 19(8):601-3. PubMed ID: 12487838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin generation in children with acute lymphoblastic leukemia: effect of leukemia immunophenotypic subgroups.
    Giordano P; Del Vecchio GC; Santoro N; Arcamone G; Coppola B; Altomare M; Schettini F; Iolascon A; De Mattia D
    Pediatr Hematol Oncol; 2000 Dec; 17(8):667-72. PubMed ID: 11127398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin deficiency after prolonged asparaginase treatment in children with acute lymphoblastic leukemia.
    Ranta S; Heyman MM; Jahnukainen K; Taskinen M; Saarinen-Pihkala UM; Frisk T; Söderhäll S; Petrini P; Mäkipernaa AM
    Blood Coagul Fibrinolysis; 2013 Oct; 24(7):749-56. PubMed ID: 24056293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study.
    Mitchell L; Andrew M; Hanna K; Abshire T; Halton J; Wu J; Anderson R; Cherrick I; Desai S; Mahoney D; McCusker P; Chait P; Abdolell M; de Veber G; Mikulis D
    Thromb Haemost; 2003 Aug; 90(2):235-44. PubMed ID: 12888870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin III as the Indicator of L-Asparaginase Activity in Children Treated for Acute Lymphoblastic Leukemia.
    Czogała M; Balwierz W; Sztefko K; Rogatko I
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):114-120. PubMed ID: 28060110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disordered hemostasis associated with severely depressed fibrinolysis demonstrated using a simultaneous thrombin and plasmin generation assay during L-asparaginase induction therapy in pediatric acute lymphoblastic leukemia.
    Ishihara T; Nogami K; Ochi S; Ishida T; Kosaka Y; Sawada A; Inoue M; Osone S; Imamura T; Hosoi H; Shima M
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28016. PubMed ID: 31556233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of thrombin generation in children with acute lymphoblastic leukemia treated by Berlin-Frankfurt-Münster (BFM) protocols.
    Lejhancova-Tousovska K; Zapletal O; Vytiskova S; Strbackova P; Sterba J
    Blood Coagul Fibrinolysis; 2012 Mar; 23(2):144-54. PubMed ID: 22227959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.